Ibezapolstat (ACX-362E)

Ibezapolstat · Acurx Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibezapolstat (ACX-362E), covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection [Phase 2]